.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
UBS
Boehringer Ingelheim
Chubb
McKinsey
Citi
Cipla
Fish and Richardson
Johnson and Johnson
Mallinckrodt

Generated: September 23, 2017

DrugPatentWatch Database Preview

Mitomycin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mitomycin and what is the scope of mitomycin freedom to operate?

Mitomycin
is the generic ingredient in four branded drugs marketed by Hospira, West-ward Pharms Int, Bristol Myers, Accord Hlthcare, Bristol, Supergen, and Mobius Therap, and is included in eight NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Mitomycin has nine patent family members in five countries.

There are seven drug master file entries for mitomycin. Three suppliers are listed for this compound.

Summary for Generic Name: mitomycin

Tradenames:4
Patents:5
Applicants:7
NDAs:8
Drug Master File Entries: see list7
Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Clinical Trials: see list178
Patent Applications: see list9,837
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mitomycin at DailyMed

Pharmacology for Ingredient: mitomycin

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064180-002Dec 23, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064117-001Apr 19, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Mobius Therap
MITOSOL
mitomycin
FOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe ► Subscribe
Bristol Myers
MUTAMYCIN
mitomycin
INJECTABLE;INJECTION062336-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers
MUTAMYCIN
mitomycin
INJECTABLE;INJECTION062336-003Mar 10, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Mobius Therap
MITOSOL
mitomycin
FOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-002Apr 30, 1998APRXNoYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064180-001Dec 23, 1999APRXNoNo► Subscribe► Subscribe► Subscribe
Bristol
MUTAMYCIN
mitomycin
INJECTABLE;INJECTION050450-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Hospira
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064106-001Nov 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: mitomycin

Country Document Number Estimated Expiration
European Patent Office2046653► Subscribe
European Patent Office3175843► Subscribe
Japan5448071► Subscribe
Australia2007272514► Subscribe
Japan2014097399► Subscribe
Japan5670546► Subscribe
World Intellectual Property Organization (WIPO)2008008802► Subscribe
Japan2009543608► Subscribe
Canada2659314► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
QuintilesIMS
Merck
Cantor Fitzgerald
Accenture
Cerilliant
US Army
Daiichi Sankyo
Covington
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot